These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1994895)

  • 21. Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the Gabon.
    Burchard GD; Kern P; Baltes R; Dietrich M
    Tropenmed Parasitol; 1984 Jun; 35(2):91-4. PubMed ID: 6464191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of chemoprotection by oltipraz.
    Kensler T; Styczynski P; Groopman J; Helzlsouer K; Curphey T; Maxuitenko Y; Roebuck BD
    J Cell Biochem Suppl; 1992; 16I():167-72. PubMed ID: 1305682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard.
    Wattenberg LW; Bueding E
    Carcinogenesis; 1986 Aug; 7(8):1379-81. PubMed ID: 3731391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention by inducers of carcinogen detoxication enzymes.
    Kensler TW
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):965-70. PubMed ID: 9255588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of 14C-oltipraz in animals. Pharmacokinetics in mice, rats and monkeys. Comparison of the biotransformation in the infected mouse and in the schistosomes.
    Heusse D; Marlard M; Bredenbac J; Decouvelaere B; Leroy JP; Bieder A; Jumeau H
    Arzneimittelforschung; 1985; 35(9):1431-6. PubMed ID: 3936507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent.
    Nelson KC; Armstrong JS; Moriarty S; Cai J; Wu MW; Sternberg P; Jones DP
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3550-4. PubMed ID: 12407167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
    Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
    Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1994; 14(1A):5-11. PubMed ID: 8166455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers.
    Kensler TW; He X; Otieno M; Egner PA; Jacobson LP; Chen B; Wang JS; Zhu YR; Zhang BC; Wang JB; Wu Y; Zhang QN; Qian GS; Kuang SY; Fang X; Li YF; Yu LY; Prochaska HJ; Davidson NE; Gordon GB; Gorman MB; Zarba A; Enger C; Muñoz A; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):127-34. PubMed ID: 9488587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice.
    Ramos-Gomez M; Dolan PM; Itoh K; Yamamoto M; Kensler TW
    Carcinogenesis; 2003 Mar; 24(3):461-7. PubMed ID: 12663505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oltipraz, a novel inhibitor of human immunodeficiency virus type 1 (HIV-1) replication.
    Prochaska HJ; Chavan SJ; Baron P; Polsky B
    J Cell Biochem Suppl; 1995; 22():117-25. PubMed ID: 8538188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
    Iida K; Itoh K; Kumagai Y; Oyasu R; Hattori K; Kawai K; Shimazui T; Akaza H; Yamamoto M
    Cancer Res; 2004 Sep; 64(18):6424-31. PubMed ID: 15374950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
    Scholl P; Musser SM; Kensler TW; Groopman JD
    Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by dietary oltipraz of experimental intestinal carcinogenesis induced by azoxymethane in male F344 rats.
    Rao CV; Tokomo K; Kelloff G; Reddy BS
    Carcinogenesis; 1991 Jun; 12(6):1051-5. PubMed ID: 2044183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-based studies reveal differences in glutathione S-transferase induction between oltipraz and tert-butylhydroquinone.
    Lamb JG; Franklin MR
    J Biochem Mol Toxicol; 2002; 16(4):154-61. PubMed ID: 12242683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis.
    Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD
    Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes.
    Antras-Ferry J; Mahéo K; Chevanne M; Dubos MP; Morel F; Guillouzo A; Cillard P; Cillard J
    Carcinogenesis; 1997 Nov; 18(11):2113-7. PubMed ID: 9395210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology studies of oltipraz--a potential chemopreventive agent.
    Dimitrov NV; Bennett JL; McMillan J; Perloff M; Leece CM; Malone W
    Invest New Drugs; 1992 Nov; 10(4):289-98. PubMed ID: 1487402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of phase 2 enzyme induction by oltipraz and other dithiolethiones.
    Egner PA; Kensler TW; Prestera T; Talalay P; Libby AH; Joyner HH; Curphey TJ
    Carcinogenesis; 1994 Feb; 15(2):177-81. PubMed ID: 8313505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
    Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
    Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.